NFKB1 and gastric cancer: OxLDL by binding to the LOX-1 receptor facilitated activation of the NFκβ pathway promoting the upregulation of VEGF-C expression in gastric cancer cells. This consequently promotes lymphangiogenesis and lymphatic metastasis of gastric cancer cells